Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Fatigue Syndrome, Chronic

tetradecanoylphorbol acetate has been researched along with Fatigue Syndrome, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosmans, E; Maes, M; Mihaylova, I1
Blauw, B; de Kloet, R; Graffelman, W; Haspels, I; Lentjes, E; Nagelkerken, L; Visser, J1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and Fatigue Syndrome, Chronic

ArticleYear
Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta.
    Neuro endocrinology letters, 2007, Volume: 28, Issue:4

    Topics: Adult; Case-Control Studies; Cell Nucleus; Fatigue Syndrome, Chronic; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Neurasthenia; NF-kappa B; Oxidative Stress; Severity of Illness Index; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2007
Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2001, Volume: 49, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cells, Cultured; Cytokines; Dexamethasone; Fatigue Syndrome, Chronic; Female; Humans; Hydrocortisone; Leukocytes, Mononuclear; Male; Middle Aged; Receptors, Glucocorticoid; Tetradecanoylphorbol Acetate

2001